For the “selenium metabolism and selenoproteins” pathway, in addition to the genes already mentioned (GPX2 and GPX3), expression of DIO1 and JUN was higher, and TXNRD3 was lower in NASH. The gene discussed is GPX2; the disease is metabolic dysfunction-associated steatohepatitis.